Clinical Research Directory
Browse clinical research sites, groups, and studies.
Lactic Acid Bacteria in Functional Diarrheal Disorders
Sponsor: Szeged University
Summary
The goal of this clinical trial is to learn whether a probiotic supplement can improve symptoms and quality of life in adults with diarrhea-predominant irritable bowel syndrome (IBS-D) or functional diarrhea (FD). These conditions can cause frequent loose stools, abdominal discomfort, and a lower quality of life. The main questions this study aims to answer are: * Does the probiotic improve quality of life compared with a placebo (a look-alike capsule that contains no active bacteria)? * Does the probiotic help participants have more normal stool consistency and fewer bowel movements? * Is the probiotic safe and well tolerated in people with IBS-D or FD? Researchers will compare the probiotic supplement with a placebo to see whether the probiotic improves symptoms and quality of life. Participants will: * Take either the probiotic or placebo capsule once daily for 3 months. * Switch to the other study treatment for an additional 3 months. * Complete quality-of-life questionnaires at the start of the study, after 3 months, and after 6 months. * Record the number of bowel movements each day throughout the study. * Record stool consistency each day using the Bristol Stool Form Scale. * Record daily pain during bowel movements using a Visual Analog Scale (VAS). * Report any medications they take and any health problems that occur during the study. The study will follow each participant for 6 months. Researchers hope the results will help determine whether this probiotic is a useful treatment option for people living with IBS-D or functional diarrhea.
Official title: Efficacy of Lactic Acid Bacteria in Managing Diarrhea-Associated Functional Gastrointestinal Disorders: A Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2026-11
Completion Date
2029-11
Last Updated
2026-11-04
Healthy Volunteers
No
Interventions
LL1500
LL1500 is an oral probiotic supplement administered once daily as a gelatin capsule. Each capsule contains lyophilized Lactobacillus rhamnosus and Lactobacillus plantarum, providing at least 7.5 × 10⁹ colony-forming units (CFU) of each bacterial strain. Participants will receive LL1500 for a 3-month treatment period.
Placebo Capsule
Matching oral placebo administered once daily as a gelatin capsule containing inactive excipients and no live bacterial strains. Participants will receive placebo for a 3-month treatment period.
Locations (1)
University of Szeged
Szeged, Hungary